Okamoto M, Kawamata H, Kawai K, Oyasu R
Department of Pathology, Northwestern University Medical School, Chicago, Illinois 60611, USA.
Cancer Res. 1995 Oct 15;55(20):4581-5.
Chronic inflammation of the urinary tract is a significant risk factor for the development of bladder cancer. We have shown that acute and chronic inflammation induced by intravesical instillations of killed Escherichia coli strikingly enhances N-methyl-N-nitrosourea (MNU)-initiated rat bladder carcinogenesis. To test the hypothesis that cytokines released during inflammation may be involved in the enhancement of bladder carcinogenesis, we conducted an in vitro experiment. Using soft agar growth as an index of transformation, we examined the effect of inflammation-associated cytokines on the enhancement of MNU-initiated transformation of MYP3 cells, an anchorage-dependent nontumorigenic rat bladder epithelial cell line. In the first experiment, after 1-h exposure to MNU (50 micrograms/ml), cells (5 x 10(4)) were grown in soft agar in the presence of interleukin (IL)-1 alpha, IL-6, IL-8, or tumor necrosis factor-alpha (10 to 100 ng/ml). Colonies consisting of more than 20 cells were counted 4 weeks later. Among the cytokines tested, IL-6 (100 ng/ml) significantly increased colony counts over those for the untreated controls (P < 0.001). In the second experiment, the cells treated with MNU similarly as in the first experiment were cultured with or without IL-6 (100 ng/ml) for 1 week before the cells (5 x 10(4)) were grown in soft agar in the presence or absence of IL-6. IL-6 pretreatment increased colony counts irrespective of subsequent IL-6 treatment (P < 0.05). Moreover, IL-6-stimulated anchorage-dependent growth of MNU transformants far exceeded that of the parental MYP3. However, among the transformants, there was no parallel relationship in response to IL-6 between anchorage-dependent and -independent growth. Our results suggest that IL-6 may provide a selective growth advantage to MNU-initiated bladder epithelial cells in vitro and that it may be a factor accounting for the marked enhancement of inflammation-associated rat bladder carcinogenesis.
尿路慢性炎症是膀胱癌发生的一个重要危险因素。我们已经表明,经膀胱灌注灭活大肠杆菌诱导的急性和慢性炎症显著增强了N-甲基-N-亚硝基脲(MNU)引发的大鼠膀胱癌发生。为了检验炎症过程中释放的细胞因子可能参与膀胱癌发生增强这一假说,我们进行了一项体外实验。以软琼脂生长作为转化指标,我们研究了炎症相关细胞因子对MNU引发的MYP3细胞(一种贴壁依赖性非致瘤性大鼠膀胱上皮细胞系)转化增强的影响。在第一个实验中,细胞(5×10⁴)在暴露于MNU(50微克/毫升)1小时后,在含有白细胞介素(IL)-1α、IL-6、IL-8或肿瘤坏死因子-α(10至100纳克/毫升)的软琼脂中培养。4周后对由超过20个细胞组成的集落进行计数。在所测试的细胞因子中,IL-6(100纳克/毫升)使集落计数显著高于未处理的对照组(P<0.001)。在第二个实验中,与第一个实验中处理方式相同的经MNU处理的细胞,在细胞(5×10⁴)于有或无IL-6存在的软琼脂中生长之前,在有或无IL-6(100纳克/毫升)的情况下培养1周。IL-6预处理增加了集落计数,而与随后是否进行IL-6处理无关(P<0.05)。此外,IL-6刺激的MNU转化细胞贴壁依赖性生长远远超过亲代MYP3细胞。然而,在转化细胞中,贴壁依赖性生长和非贴壁依赖性生长对IL-6的反应之间没有平行关系。我们的结果表明,IL-6可能在体外为MNU引发的膀胱上皮细胞提供选择性生长优势,并且它可能是炎症相关大鼠膀胱癌发生显著增强的一个因素。